SMURF2 and breast carcinoma: TRAF4 modulates canonical signaling in breast cancer cells by ubiquitinating SMURF2 for destruction and mediates non-canonical signaling in a Traf6-independent manner, stabilizing TGFBR at the plasma membrane.